Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-07

Clinical Trial Update: SUBLIVAC® Birch PROBE Study [Phase 2]

View source ↗

Summary

A Phase 2 trial of SUBLIVAC Birch PROBE for birch pollen allergy and seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUBLIVAC Birch PROBE

Snippet

Sponsor: HAL Allergy | Conditions: Seasonal Rhinitis and/or Rhinoconjunctivitis, Birch Pollen Allergy | Phase 2 | Status: COMPLETED